Clinical Trial Update: Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors [Phase 2]

View source ↗

Summary

Phase 2 results evaluating combined modality treatment for resectable non-small cell lung cancer in the superior sulcus (Pancoast) region.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED